Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ALI HEALTH
00241
5
TRIP.COM-S
09961
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -6.19%172.97B | -5.70%112.03B | -7.70%60.33B | -3.48%245.55B | -3.62%184.4B | -5.73%118.81B | 0.15%65.37B | 3.11%254.4B | 4.01%191.32B | 7.84%126.03B |
| Operating income | -6.19%172.97B | -5.70%112.03B | -7.70%60.33B | -3.48%245.55B | -3.62%184.4B | -5.73%118.81B | 0.15%65.37B | 3.11%254.4B | 4.01%191.32B | 7.84%126.03B |
| Operating expenses | 10.58%-138.47B | 10.97%-48.84B | 7.12%-154.85B | 6.53%-54.86B | 7.01%-166.72B | |||||
| Gross profit | 16.77%34.51B | 9.37%11.49B | 20.10%29.55B | 59.71%10.51B | 428.01%24.6B | |||||
| Selling expenses | -8.34%-195.22M | ---- | -17.00%-55.7M | ---- | 6.51%-180.19M | ---- | 4.15%-47.6M | ---- | -15.28%-192.74M | ---- |
| Administrative expenses | -5.62%-4.85B | ---- | -10.36%-1.52B | ---- | -11.34%-4.6B | ---- | -5.76%-1.38B | ---- | -10.68%-4.13B | ---- |
| Research and development expenses | 17.07%-956.07M | ---- | -14.13%-234.95M | ---- | -31.62%-1.15B | ---- | -5.35%-205.86M | ---- | -30.26%-875.84M | ---512.85M |
| Profit from asset sales | 2,230.68%176.99M | ---- | 4,155.06%2.33M | ---- | -109.60%-8.31M | ---- | -91.86%54.82K | ---- | -19.40%86.57M | ---- |
| Employee expense | ---- | -3.85%-9.02B | ---- | -5.00%-18.65B | ---- | -17.07%-8.68B | ---- | -10.00%-17.76B | ---- | -10.16%-7.42B |
| Depreciation and amortization | ---- | -6.47%-13.56B | ---- | -3.18%-26.3B | ---- | -1.00%-12.74B | ---- | -4.56%-25.49B | ---- | -5.32%-12.61B |
| Impairment and provision | 40.70%-626.78M | -119.46%-3.79M | 355.65%22.06M | 84.33%-20.22M | -653.76%-1.06B | 131.38%19.49M | -794.95%-8.63M | -167.34%-129.01M | -97.89%-140.23M | 4.19%-62.11M |
| -Other impairment is provision | 40.70%-626.78M | -119.46%-3.79M | 355.65%22.06M | 84.33%-20.22M | -653.76%-1.06B | 131.38%19.49M | -794.95%-8.63M | -167.34%-129.01M | -97.89%-140.23M | 4.19%-62.11M |
| Special items of operating profit | -8.79%1.6B | 13.76%-70.72B | 8.98%748M | 8.51%-174.57B | -61.50%1.75B | 11.48%-82.01B | 29.15%686.39M | 7.85%-190.82B | 102.59%4.55B | 5.27%-92.65B |
| Operating profit | 21.82%27.88B | 21.57%17.62B | 9.24%9.9B | 29.29%24B | 0.72%22.88B | 20.28%14.49B | 74.79%9.06B | 881.58%18.56B | 1,604.71%22.72B | 3,582.97%12.05B |
| Financing income | ---- | -37.46%186.73M | ---- | 19.54%605.92M | ---- | 41.97%298.56M | ---- | 49.41%506.88M | ---- | 31.74%210.3M |
| Financing cost | 16.50%-4.98B | 13.36%-3.5B | 15.12%-1.74B | 12.88%-7.79B | 11.53%-5.96B | 11.16%-4.04B | 3.74%-2.05B | 10.28%-8.94B | 7.30%-6.73B | 10.90%-4.55B |
| Share of profits of associates | ---- | -10.86%764.89M | ---- | 47.50%1.26B | ---- | 9.94%858.12M | ---- | -18.04%854.16M | ---- | 15.89%780.55M |
| Special items of earning before tax | ---- | 72.12%-64.98M | ---- | -117.12%-255.59M | ---- | -312.67%-233.09M | ---- | 954.63%1.49B | ---- | -167.10%-56.48M |
| Adjustment items of earning before tax | 155.45%257.82M | ---- | 459.26%45.75M | ---- | -672.66%-464.95M | ---- | -117.26%-12.73M | ---- | -68.93%81.19M | ---- |
| Earning before tax | 40.70%23.16B | 31.90%15.01B | 17.22%8.2B | 42.83%17.82B | 2.45%16.46B | 34.86%11.38B | 123.64%7B | 215.38%12.48B | 383.32%16.07B | 286.01%8.44B |
| Tax | -19.96%-3.72B | -22.73%-2.39B | -7.12%-1.24B | -2.90%-3.82B | -18.79%-3.1B | -19.66%-1.95B | -74.52%-1.16B | -2,236.93%-3.71B | -1,509.80%-2.61B | -552.14%-1.63B |
| After-tax profit from continuing operations | 45.52%19.44B | 33.80%12.62B | 19.22%6.96B | 59.72%14.01B | -0.73%13.36B | 38.50%9.43B | 136.91%5.84B | 179.92%8.77B | 345.26%13.45B | 263.08%6.81B |
| Earning after tax | 45.52%19.44B | 33.80%12.62B | 19.22%6.96B | 59.72%14.01B | -0.73%13.36B | 38.50%9.43B | 136.91%5.84B | 179.92%8.77B | 345.26%13.45B | 263.08%6.81B |
| Minority profit | 56.13%4.6B | 83.60%3.04B | 60.06%1.99B | 827.68%3.82B | 230.60%2.94B | 418.18%1.66B | 480.79%1.24B | 113.98%411.95M | 157.69%890.29M | 133.45%319.48M |
| Profit attributable to shareholders | 42.52%14.84B | 23.19%9.58B | 8.19%4.97B | 21.86%10.18B | -17.12%10.41B | 19.81%7.77B | 104.25%4.6B | 204.13%8.36B | 418.69%12.56B | 301.53%6.49B |
| Basic earnings per share | 52.83%0.81 | 30.00%0.52 | 8.00%0.27 | 31.43%0.46 | -19.70%0.53 | 25.00%0.4 | 150.00%0.25 | 153.85%0.35 | 288.57%0.66 | 218.52%0.32 |
| Diluted earnings per share | 52.83%0.81 | 30.00%0.52 | 8.00%0.27 | 31.43%0.46 | -19.70%0.53 | 25.00%0.4 | 150.00%0.25 | 153.85%0.35 | 288.57%0.66 | 218.52%0.32 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | -- | -- | Ernst & Young Huaming, Ernst & Young (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.